Cancer Genetics Inc (CGIX) stock is up 45% this week. CGIX stock has fallen -82.42% over the last 12 months, and the average rating from Wall Street analysts is a Hold. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives CGIX stock a score of 46 out of a possible 100.
That score is chiefly influenced by a fundamental score of 10. CGIX’s score also includes a short-term technical score of 60. The long-term technical score for CGIX is 68.
What’s Happening with CGIX Stock Today
Cancer Genetics Inc (CGIX) stock has gained 5.23% while the S&P 500 has fallen -0.84% as of 12:49 PM on Tuesday, Oct 8. CGIX is higher by $0.01 from the previous closing price of $0.15 on volume of 12,399,921 shares. Over the past year the S&P 500 has gained 1.02% while CGIX has fallen -82.42%. CGIX lost -$0.75 per share in the over the last 12 months.